glp-1 news oct 9 2025 insurance coverage worsened at start of 2025, report says Understanding GLP-1s and their dynamic

The risk of depression associated with GLP-1RAs remains inconclusive, as studies have reported both an increased and decreased risk [18, 19]

SPINK1 p.N34S variant weakens trypsin inhibition, conferring an approximately 2.8-fold increased risk of elevated pancreatic enzymes and gastrointestinal symptoms during GLP-1RA therapy [60,61]

Similarly, there was no efflux system for [Ser 8 ]GLP-1 to exit the brain other than following the reabsorption of cerebrospinal fluid (CSF)

Kisiel a Krishna Unadkat b Shelley S

Feeling Cold on Ozempic: Causes and Management Feeling cold whilst taking Ozempic (semaglutide) is an experience reported by some patients, though it is not listed as an official adverse effect in UK regulatory documentation

In Alzheimers disease, six-month treatment with GLP-1 analogue prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial